Despite a wide range, the median serum BAFF level in patients with AIH before treatment was significantly higher compared with healthy controls (517 pg/ml [range 85–2182] vs. 326 pg/ml [range 258–398]; p = 0.003). The gene discussed is TNFSF13B; the disease is autoimmune hepatitis.